
Asembia 2025: Rare Disease Therapies Drive Shift in Drug Development Focus
In an interview with Pharmaceutical Commerce, a session leader from “U.S. Pharmaceutical Transitions: What’s Next?” shared key insights on the current and future state of the market. The conversation highlighted the rapid growth of specialty …